Replies to post #104386 on Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

That chart reminded me: we haven't gone from .085 cents to .1235 cents on this last run, we've gone from .068 cents to .1235 cents. That is almost double!! A very nice 2 month run! I expect we'll do twice as well as that in the next two months.

[jrock777]

I believe IMO that people shouldn't be expecting a big up front payment from a big pharma, but should be happy with the stamp of approval from a BP. Investors have to remember that whoever is our partner will be taking on a lot of the expenses making the test, cost of marketing, and up front equipment, and employees working with us. The value is not in the upfront payment, but the longevity of the BP bringing in revenue and making Lympro the gold standard.

[jacmar1965]

This thing is screaming .18 cents!